Micah Maxwell

Articles by Micah Maxwell

31 TIP TROPION-Breast03: Datopotamab Deruxtecan (Dato-DXd) ± Durvalumab vs Investigator’s Choice of Therapy (ICT) for Triple-Negative Breast Cancer (TNBC) with Residual Disease Following Neoadjuvant Therapy

ByAditya Bardia, MD, MPH, FASCO,Lajos Pusztai, MD, DPhil,Kathy S. Albain, MD,Kevin Kalinsky, MD, MS,Dawn Herman,William Barlow,Claudine Isaacs, MD,Micah Maxwell,Nadia Harbeck, MD, PhD,Priyanka Sharma, MD

April 27th 2023

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Tucatinib Combo as Maintenance in HER2+ Breast Cancer

Personalized Vaccines May Have Utility Across All Lung Cancer Stages

Firmonertinib Misses PFS End Point in First-Line EGFR Exon 20 NSCLC

Clinical Applications and the Future of Remote Endovascular Procedures

Avutometinib/Defactinib Shows Activity in KRAS Wild-Type Recurrent LGSOC